Record-Breaking Quarterly Financial Performance
Balchem Corporation reported record quarterly consolidated revenue of $268 million, up 11.5% from the prior year, and record quarterly GAAP earnings from operations of $55 million, an increase of 13.7%.
Human Nutrition and Health Segment Growth
The Human Nutrition and Health segment generated record sales of $174 million, an increase of 14.3% from the prior year, driven by strong demand for its unique portfolio of minerals, nutrients, and vitamins.
Animal Nutrition and Health Segment Performance
Generated quarterly sales of $56 million, an increase of 6.6% compared to the prior year, driven by higher sales in both the ruminant and monogastric businesses.
Specialty Products Segment Success
The Specialty Products segment delivered quarterly sales of $36 million, an increase of 7.5% compared to the prior year, driven by higher sales in both the Performance Gases and Plant Nutrition businesses.
Persistent Market Demand and Strategic Growth
Healthy demand across end markets and strategic growth initiatives, including geographic expansion in Plant Nutrition and Performance Gases, contributed to positive results.
Scientific Advancements
Completion of an NIH-funded choline biomarker study, enhancing the ability to assess choline dietary adequacy and supporting market penetration efforts.